

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 5.93030635 |
| 2 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.84724715 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.69726639 |
| 4 | glutamate secretion (GO:0014047) | 5.22282587 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.13626693 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 5.01528787 |
| 7 | locomotory exploration behavior (GO:0035641) | 4.85324528 |
| 8 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.71631108 |
| 9 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.36669765 |
| 10 | vocalization behavior (GO:0071625) | 4.21657659 |
| 11 | regulation of synaptic vesicle transport (GO:1902803) | 4.16342043 |
| 12 | neurotransmitter secretion (GO:0007269) | 4.16085962 |
| 13 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 4.09483712 |
| 14 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.92569727 |
| 15 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.90458427 |
| 16 | neuronal action potential propagation (GO:0019227) | 3.90128514 |
| 17 | regulation of synapse structural plasticity (GO:0051823) | 3.89810618 |
| 18 | sodium ion export (GO:0071436) | 3.89187364 |
| 19 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.85952434 |
| 20 | activation of protein kinase A activity (GO:0034199) | 3.82300980 |
| 21 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.81109061 |
| 22 | cellular potassium ion homeostasis (GO:0030007) | 3.77132636 |
| 23 | layer formation in cerebral cortex (GO:0021819) | 3.76159757 |
| 24 | proline transport (GO:0015824) | 3.75636315 |
| 25 | cell communication by electrical coupling (GO:0010644) | 3.73170352 |
| 26 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.72737354 |
| 27 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.71334747 |
| 28 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.67242622 |
| 29 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.62577059 |
| 30 | protein localization to synapse (GO:0035418) | 3.54336641 |
| 31 | exploration behavior (GO:0035640) | 3.50502596 |
| 32 | Golgi transport vesicle coating (GO:0048200) | 3.48065526 |
| 33 | COPI coating of Golgi vesicle (GO:0048205) | 3.48065526 |
| 34 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.45752965 |
| 35 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.44244487 |
| 36 | positive regulation of synapse maturation (GO:0090129) | 3.43171903 |
| 37 | negative regulation of Ras GTPase activity (GO:0034261) | 3.40845090 |
| 38 | mannose metabolic process (GO:0006013) | 3.38347493 |
| 39 | plasma membrane repair (GO:0001778) | 3.36387234 |
| 40 | neuromuscular process controlling posture (GO:0050884) | 3.31058851 |
| 41 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.30820384 |
| 42 | cerebellar Purkinje cell layer development (GO:0021680) | 3.19393953 |
| 43 | creatine metabolic process (GO:0006600) | 3.18119980 |
| 44 | membrane depolarization during action potential (GO:0086010) | 3.14919209 |
| 45 | gamma-aminobutyric acid transport (GO:0015812) | 3.14639369 |
| 46 | cerebellar granule cell differentiation (GO:0021707) | 3.14258759 |
| 47 | negative regulation of microtubule polymerization (GO:0031115) | 3.13749917 |
| 48 | neurotransmitter transport (GO:0006836) | 3.12804285 |
| 49 | neuromuscular process controlling balance (GO:0050885) | 3.12068219 |
| 50 | protein retention in ER lumen (GO:0006621) | 3.08796462 |
| 51 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.04354467 |
| 52 | regulation of synaptic plasticity (GO:0048167) | 3.03251882 |
| 53 | regulation of neurotransmitter secretion (GO:0046928) | 3.02752512 |
| 54 | cell communication involved in cardiac conduction (GO:0086065) | 3.02581781 |
| 55 | activation of MAPKKK activity (GO:0000185) | 3.01715540 |
| 56 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.99459483 |
| 57 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.99309907 |
| 58 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.97269053 |
| 59 | synaptic transmission, glutamatergic (GO:0035249) | 2.97262158 |
| 60 | alanine transport (GO:0032328) | 2.95615565 |
| 61 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.94136280 |
| 62 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.93489900 |
| 63 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.91453717 |
| 64 | vesicle transport along microtubule (GO:0047496) | 2.91374193 |
| 65 | regulation of neurotransmitter levels (GO:0001505) | 2.91363185 |
| 66 | regulation of beta-amyloid formation (GO:1902003) | 2.89085423 |
| 67 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.88910637 |
| 68 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.87836341 |
| 69 | neuron-neuron synaptic transmission (GO:0007270) | 2.87396650 |
| 70 | positive regulation of membrane potential (GO:0045838) | 2.86825817 |
| 71 | signal complex assembly (GO:0007172) | 2.86580051 |
| 72 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.85735679 |
| 73 | neuron cell-cell adhesion (GO:0007158) | 2.85503121 |
| 74 | synaptic vesicle endocytosis (GO:0048488) | 2.84081345 |
| 75 | glycine transport (GO:0015816) | 2.83619630 |
| 76 | membrane repolarization (GO:0086009) | 2.83282929 |
| 77 | peptidyl-lysine dimethylation (GO:0018027) | 2.82589915 |
| 78 | dendrite morphogenesis (GO:0048813) | 2.81057339 |
| 79 | regulation of neurotransmitter transport (GO:0051588) | 2.80878523 |
| 80 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.80694286 |
| 81 | potassium ion import (GO:0010107) | 2.80592962 |
| 82 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.80221214 |
| 83 | positive regulation of neurotransmitter transport (GO:0051590) | 2.79683409 |
| 84 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.79559898 |
| 85 | cell migration in hindbrain (GO:0021535) | 2.77284422 |
| 86 | long-term memory (GO:0007616) | 2.76795935 |
| 87 | regulation of postsynaptic membrane potential (GO:0060078) | 2.76322374 |
| 88 | regulation of ARF GTPase activity (GO:0032312) | 2.76261889 |
| 89 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.73986810 |
| 90 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.73830755 |
| 91 | innervation (GO:0060384) | 2.72397487 |
| 92 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.69036177 |
| 93 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.68974522 |
| 94 | positive regulation of fibroblast migration (GO:0010763) | 2.68819685 |
| 95 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.68500408 |
| 96 | protein localization to endosome (GO:0036010) | 2.67685352 |
| 97 | cellular sodium ion homeostasis (GO:0006883) | 2.67676252 |
| 98 | dendritic spine morphogenesis (GO:0060997) | 2.67209215 |
| 99 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.66928357 |
| 100 | regulation of membrane repolarization (GO:0060306) | 2.66363950 |
| 101 | chemosensory behavior (GO:0007635) | 2.66264216 |
| 102 | neuronal ion channel clustering (GO:0045161) | 2.66242093 |
| 103 | negative regulation of Ras protein signal transduction (GO:0046580) | 2.66026612 |
| 104 | regulation of extracellular matrix disassembly (GO:0010715) | 2.64514853 |
| 105 | organelle transport along microtubule (GO:0072384) | 2.63905670 |
| 106 | positive regulation of sodium ion transport (GO:0010765) | 2.63730212 |
| 107 | neuromuscular process (GO:0050905) | 2.62093955 |
| 108 | establishment of nucleus localization (GO:0040023) | 2.62055398 |
| 109 | regulation of autophagic vacuole assembly (GO:2000785) | 2.61518469 |
| 110 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.60637287 |
| 111 | regulation of ion transmembrane transporter activity (GO:0032412) | 2.60370705 |
| 112 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.60276893 |
| 113 | regulation of ARF protein signal transduction (GO:0032012) | 2.60225818 |
| 114 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.59507073 |
| 115 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.59467328 |
| 116 | neuromuscular synaptic transmission (GO:0007274) | 2.59432389 |
| 117 | negative regulation of cell size (GO:0045792) | 2.58827778 |
| 118 | long-term synaptic potentiation (GO:0060291) | 2.58760792 |
| 119 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.58447747 |
| 120 | regulation of vesicle fusion (GO:0031338) | 2.58384361 |
| 121 | potassium ion homeostasis (GO:0055075) | 2.58200332 |
| 122 | prepulse inhibition (GO:0060134) | 2.58124477 |
| 123 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.57192802 |
| 124 | positive regulation of Rap GTPase activity (GO:0032854) | 2.56784480 |
| 125 | membrane depolarization (GO:0051899) | 2.56764342 |
| 126 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.56037883 |
| 127 | regulation of early endosome to late endosome transport (GO:2000641) | 2.54777648 |
| 128 | membrane repolarization during action potential (GO:0086011) | 2.54709836 |
| 129 | negative regulation of small GTPase mediated signal transduction (GO:0051058) | 2.51617752 |
| 130 | barbed-end actin filament capping (GO:0051016) | 2.50403121 |
| 131 | negative regulation of GTP catabolic process (GO:0033125) | 2.48258773 |
| 132 | negative regulation of GTPase activity (GO:0034260) | 2.48258773 |
| 133 | dopamine receptor signaling pathway (GO:0007212) | 2.47465109 |
| 134 | response to parathyroid hormone (GO:0071107) | 2.47014304 |
| 135 | negative regulation of nucleotide catabolic process (GO:0030812) | 2.45928922 |
| 136 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.44594710 |
| 137 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.44264038 |
| 138 | negative regulation of cell killing (GO:0031342) | 2.43272554 |
| 139 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.43272554 |
| 140 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.43129442 |
| 141 | regulation of cellular amide metabolic process (GO:0034248) | 2.41816589 |
| 142 | regulation of synapse maturation (GO:0090128) | 2.38826413 |
| 143 | positive regulation of protein dephosphorylation (GO:0035307) | 2.38655328 |
| 144 | cell-cell junction maintenance (GO:0045217) | 2.36756237 |
| 145 | thymic T cell selection (GO:0045061) | 2.35780150 |
| 146 | protein targeting to plasma membrane (GO:0072661) | 2.35526587 |
| 147 | retrograde transport, endosome to Golgi (GO:0042147) | 2.34082444 |
| 148 | regulation of vacuole organization (GO:0044088) | 2.33921249 |
| 149 | stress fiber assembly (GO:0043149) | 2.33593269 |
| 150 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.28939285 |
| 151 | regulation of defense response to virus by virus (GO:0050690) | 2.28791788 |
| 152 | response to muramyl dipeptide (GO:0032495) | 2.28474844 |
| 153 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.28244833 |
| 154 | localization within membrane (GO:0051668) | 2.28104611 |
| 155 | adherens junction assembly (GO:0034333) | 2.27332202 |
| 156 | NADH metabolic process (GO:0006734) | 2.27090814 |
| 157 | cardiac muscle contraction (GO:0060048) | 2.26420185 |
| 158 | cell-substrate adherens junction assembly (GO:0007045) | 2.24400556 |
| 159 | focal adhesion assembly (GO:0048041) | 2.24400556 |
| 160 | cellular response to catecholamine stimulus (GO:0071870) | 2.24389040 |
| 161 | cellular response to monoamine stimulus (GO:0071868) | 2.24389040 |
| 162 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.23451385 |
| 163 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.22961859 |
| 164 | negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059) | 2.20761016 |
| 165 | negative regulation of purine nucleotide catabolic process (GO:0033122) | 2.20481990 |
| 166 | regulation of extracellular matrix organization (GO:1903053) | 2.20433165 |
| 167 | negative regulation of ERBB signaling pathway (GO:1901185) | 2.15755465 |
| 168 | NIK/NF-kappaB signaling (GO:0038061) | 2.15578273 |
| 169 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.15133857 |
| 170 | activation of Rac GTPase activity (GO:0032863) | 2.14510220 |
| 171 | modulation by symbiont of host cellular process (GO:0044068) | 2.13268842 |
| 172 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.11619048 |
| 173 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.11577698 |
| 174 | autophagic vacuole fusion (GO:0000046) | 2.09821934 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.90980526 |
| 2 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.90421033 |
| 3 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.73259552 |
| 4 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.63997377 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.63147488 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.62248083 |
| 7 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.58459419 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.55831293 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.55831293 |
| 10 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.45415989 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.37560776 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.36817825 |
| 13 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.32312713 |
| 14 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.31240310 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.30986511 |
| 16 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.30962622 |
| 17 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.25908712 |
| 18 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.18958571 |
| 19 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.18411178 |
| 20 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.18151898 |
| 21 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.14065056 |
| 22 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.13687456 |
| 23 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.07023041 |
| 24 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.06074716 |
| 25 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.03205516 |
| 26 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.02925477 |
| 27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.98579761 |
| 28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.97452494 |
| 29 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.96271855 |
| 30 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.94523735 |
| 31 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.91502040 |
| 32 | MYC_22102868_ChIP-Seq_BL_Human | 1.91426112 |
| 33 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.89863111 |
| 34 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.88767280 |
| 35 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.87451903 |
| 36 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.85660811 |
| 37 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.84481572 |
| 38 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.80872093 |
| 39 | KDM2B_26808549_Chip-Seq_K562_Human | 1.80062559 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.79082254 |
| 41 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.78418626 |
| 42 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.78281187 |
| 43 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.77309547 |
| 44 | P68_20966046_ChIP-Seq_HELA_Human | 1.77023512 |
| 45 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.76705631 |
| 46 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.76233593 |
| 47 | * SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.65483240 |
| 48 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.61572021 |
| 49 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.57490281 |
| 50 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.55159320 |
| 51 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.51112961 |
| 52 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.50346219 |
| 53 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.48512991 |
| 54 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.48091345 |
| 55 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.45858201 |
| 56 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.45655371 |
| 57 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.44515838 |
| 58 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.40896704 |
| 59 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.39237391 |
| 60 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.38215420 |
| 61 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.37474033 |
| 62 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.35427697 |
| 63 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.35037399 |
| 64 | MAF_26560356_Chip-Seq_TH2_Human | 1.33804494 |
| 65 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.33254425 |
| 66 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.32390792 |
| 67 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.31842073 |
| 68 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.30437317 |
| 69 | MAF_26560356_Chip-Seq_TH1_Human | 1.29507478 |
| 70 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.28398057 |
| 71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.27609555 |
| 72 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.27140829 |
| 73 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.26082952 |
| 74 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.25345908 |
| 75 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.25031254 |
| 76 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.23928719 |
| 77 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.23556532 |
| 78 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.23538553 |
| 79 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.22912989 |
| 80 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.20340643 |
| 81 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.19844414 |
| 82 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18372102 |
| 83 | AR_19668381_ChIP-Seq_PC3_Human | 1.18311097 |
| 84 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15807315 |
| 85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15259696 |
| 86 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.15171670 |
| 87 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.15019171 |
| 88 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.15016431 |
| 89 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.14384223 |
| 90 | UTX_26944678_Chip-Seq_JUKART_Human | 1.14124641 |
| 91 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.12929863 |
| 92 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12614762 |
| 93 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.12005984 |
| 94 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11489961 |
| 95 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.11454508 |
| 96 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11078961 |
| 97 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.09182054 |
| 98 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.09125796 |
| 99 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.08012988 |
| 100 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.07216658 |
| 101 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.06756967 |
| 102 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.06726971 |
| 103 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.06284044 |
| 104 | SA1_27219007_Chip-Seq_Bcells_Human | 1.03765188 |
| 105 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.02578527 |
| 106 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.02084295 |
| 107 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.01974865 |
| 108 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.01298280 |
| 109 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.01106473 |
| 110 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.00899827 |
| 111 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.00419823 |
| 112 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.00394770 |
| 113 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.00242236 |
| 114 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.99999516 |
| 115 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.99021492 |
| 116 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98629760 |
| 117 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.97604394 |
| 118 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.97406742 |
| 119 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97275617 |
| 120 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.97158161 |
| 121 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.97045016 |
| 122 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97037346 |
| 123 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.96868333 |
| 124 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96790281 |
| 125 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.96305844 |
| 126 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.96245763 |
| 127 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95551982 |
| 128 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.95409956 |
| 129 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.95226165 |
| 130 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.94865238 |
| 131 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.94805797 |
| 132 | * ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.94588669 |
| 133 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.94155248 |
| 134 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.93952879 |
| 135 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.93788151 |
| 136 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.93087683 |
| 137 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.92805671 |
| 138 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.92584042 |
| 139 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.92565132 |
| 140 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.91511144 |
| 141 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.91160831 |
| 142 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.91079976 |
| 143 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.90303852 |
| 144 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.89583230 |
| 145 | RXR_22108803_ChIP-Seq_LS180_Human | 0.89467248 |
| 146 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.88962514 |
| 147 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.88040581 |
| 148 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.87422111 |
| 149 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.86956685 |
| 150 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.85914341 |
| 151 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.85507837 |
| 152 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85412917 |
| 153 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.82638930 |
| 154 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.81454335 |
| 155 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.81415132 |
| 156 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.80807364 |
| 157 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.80245709 |
| 158 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.79647055 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.19347995 |
| 2 | MP0003303_peritoneal_inflammation | 4.30654461 |
| 3 | MP0004270_analgesia | 3.62633911 |
| 4 | MP0000566_synostosis | 3.56118190 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 3.52082212 |
| 6 | MP0003880_abnormal_central_pattern | 2.99817518 |
| 7 | MP0001968_abnormal_touch/_nociception | 2.90611770 |
| 8 | MP0004858_abnormal_nervous_system | 2.71756012 |
| 9 | MP0002063_abnormal_learning/memory/cond | 2.68584628 |
| 10 | MP0009745_abnormal_behavioral_response | 2.57485324 |
| 11 | MP0002064_seizures | 2.56585721 |
| 12 | MP0009046_muscle_twitch | 2.50933750 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.38462959 |
| 14 | MP0005451_abnormal_body_composition | 2.37960569 |
| 15 | MP0002822_catalepsy | 2.37668534 |
| 16 | MP0005058_abnormal_lysosome_morphology | 2.35877215 |
| 17 | MP0000751_myopathy | 2.26292842 |
| 18 | MP0002736_abnormal_nociception_after | 2.23418485 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 2.20593771 |
| 20 | MP0000604_amyloidosis | 2.16151159 |
| 21 | MP0002735_abnormal_chemical_nociception | 2.12959843 |
| 22 | MP0002272_abnormal_nervous_system | 2.07368190 |
| 23 | MP0002572_abnormal_emotion/affect_behav | 2.04296602 |
| 24 | MP0002909_abnormal_adrenal_gland | 2.01052944 |
| 25 | MP0000013_abnormal_adipose_tissue | 1.92273189 |
| 26 | MP0001348_abnormal_lacrimal_gland | 1.89777914 |
| 27 | MP0002733_abnormal_thermal_nociception | 1.89607304 |
| 28 | MP0003436_decreased_susceptibility_to | 1.86011939 |
| 29 | MP0002837_dystrophic_cardiac_calcinosis | 1.85662570 |
| 30 | MP0005423_abnormal_somatic_nervous | 1.84832076 |
| 31 | MP0004811_abnormal_neuron_physiology | 1.82608236 |
| 32 | MP0004510_myositis | 1.75748218 |
| 33 | MP0004145_abnormal_muscle_electrophysio | 1.75253677 |
| 34 | MP0003705_abnormal_hypodermis_morpholog | 1.73969630 |
| 35 | MP0001970_abnormal_pain_threshold | 1.71758341 |
| 36 | MP0003329_amyloid_beta_deposits | 1.70987407 |
| 37 | MP0008260_abnormal_autophagy | 1.70082890 |
| 38 | MP0009840_abnormal_foam_cell | 1.69072361 |
| 39 | MP0004233_abnormal_muscle_weight | 1.67751605 |
| 40 | MP0008569_lethality_at_weaning | 1.64968292 |
| 41 | MP0003172_abnormal_lysosome_physiology | 1.63622279 |
| 42 | MP0003283_abnormal_digestive_organ | 1.61265730 |
| 43 | MP0002184_abnormal_innervation | 1.60958016 |
| 44 | MP0002067_abnormal_sensory_capabilities | 1.60542153 |
| 45 | MP0001486_abnormal_startle_reflex | 1.59210825 |
| 46 | MP0001501_abnormal_sleep_pattern | 1.53439315 |
| 47 | MP0001440_abnormal_grooming_behavior | 1.49906681 |
| 48 | MP0003300_gastrointestinal_ulcer | 1.48636449 |
| 49 | MP0005623_abnormal_meninges_morphology | 1.47022398 |
| 50 | MP0003122_maternal_imprinting | 1.46696518 |
| 51 | MP0005666_abnormal_adipose_tissue | 1.44218686 |
| 52 | MP0003879_abnormal_hair_cell | 1.42684103 |
| 53 | MP0000747_muscle_weakness | 1.41860038 |
| 54 | MP0008961_abnormal_basal_metabolism | 1.39615760 |
| 55 | MP0000955_abnormal_spinal_cord | 1.37536256 |
| 56 | MP0001984_abnormal_olfaction | 1.36839821 |
| 57 | MP0005166_decreased_susceptibility_to | 1.36015414 |
| 58 | MP0003690_abnormal_glial_cell | 1.34506875 |
| 59 | MP0003191_abnormal_cellular_cholesterol | 1.32062542 |
| 60 | MP0004185_abnormal_adipocyte_glucose | 1.29241087 |
| 61 | MP0003763_abnormal_thymus_physiology | 1.28970280 |
| 62 | MP0003183_abnormal_peptide_metabolism | 1.28209433 |
| 63 | MP0002557_abnormal_social/conspecific_i | 1.28001956 |
| 64 | MP0000678_abnormal_parathyroid_gland | 1.27602756 |
| 65 | MP0000749_muscle_degeneration | 1.26254006 |
| 66 | MP0006276_abnormal_autonomic_nervous | 1.25369240 |
| 67 | MP0003453_abnormal_keratinocyte_physiol | 1.25347370 |
| 68 | MP0005375_adipose_tissue_phenotype | 1.23778323 |
| 69 | MP0004924_abnormal_behavior | 1.23401419 |
| 70 | MP0005386_behavior/neurological_phenoty | 1.23401419 |
| 71 | MP0001849_ear_inflammation | 1.22168580 |
| 72 | MP0006082_CNS_inflammation | 1.21712538 |
| 73 | MP0002882_abnormal_neuron_morphology | 1.20118907 |
| 74 | MP0003633_abnormal_nervous_system | 1.19562712 |
| 75 | MP0004130_abnormal_muscle_cell | 1.19502825 |
| 76 | MP0001958_emphysema | 1.18408670 |
| 77 | MP0003646_muscle_fatigue | 1.17650647 |
| 78 | MP0002066_abnormal_motor_capabilities/c | 1.17303026 |
| 79 | MP0001663_abnormal_digestive_system | 1.16409367 |
| 80 | MP0004215_abnormal_myocardial_fiber | 1.16008665 |
| 81 | MP0000003_abnormal_adipose_tissue | 1.15706194 |
| 82 | MP0004947_skin_inflammation | 1.14748231 |
| 83 | MP0010234_abnormal_vibrissa_follicle | 1.11412571 |
| 84 | MP0004084_abnormal_cardiac_muscle | 1.11218002 |
| 85 | MP0005409_darkened_coat_color | 1.11088475 |
| 86 | MP0009278_abnormal_bone_marrow | 1.11083522 |
| 87 | MP0000920_abnormal_myelination | 1.09730657 |
| 88 | MP0002269_muscular_atrophy | 1.07883888 |
| 89 | MP0003279_aneurysm | 1.07565267 |
| 90 | MP0010155_abnormal_intestine_physiology | 1.07413873 |
| 91 | MP0005076_abnormal_cell_differentiation | 1.07219688 |
| 92 | MP0000858_altered_metastatic_potential | 1.06700311 |
| 93 | MP0004036_abnormal_muscle_relaxation | 1.06105761 |
| 94 | MP0000778_abnormal_nervous_system | 1.05436867 |
| 95 | MP0002249_abnormal_larynx_morphology | 1.04312309 |
| 96 | MP0004085_abnormal_heartbeat | 1.00392255 |
| 97 | MP0000681_abnormal_thyroid_gland | 0.98375234 |
| 98 | MP0004087_abnormal_muscle_fiber | 0.97868886 |
| 99 | MP0001299_abnormal_eye_distance/ | 0.97583466 |
| 100 | MP0003866_abnormal_defecation | 0.96524631 |
| 101 | MP0004885_abnormal_endolymph | 0.96097532 |
| 102 | MP0005025_abnormal_response_to | 0.94503572 |
| 103 | MP0005381_digestive/alimentary_phenotyp | 0.93508705 |
| 104 | MP0000759_abnormal_skeletal_muscle | 0.92806049 |
| 105 | MP0010386_abnormal_urinary_bladder | 0.92330067 |
| 106 | MP0005499_abnormal_olfactory_system | 0.92226207 |
| 107 | MP0005394_taste/olfaction_phenotype | 0.92226207 |
| 108 | MP0003091_abnormal_cell_migration | 0.92208914 |
| 109 | MP0005000_abnormal_immune_tolerance | 0.90636203 |
| 110 | MP0003631_nervous_system_phenotype | 0.90427242 |
| 111 | MP0005387_immune_system_phenotype | 0.89309678 |
| 112 | MP0001790_abnormal_immune_system | 0.89309678 |
| 113 | MP0004484_altered_response_of | 0.89222795 |
| 114 | MP0002152_abnormal_brain_morphology | 0.88910558 |
| 115 | MP0003787_abnormal_imprinting | 0.88285046 |
| 116 | MP0001664_abnormal_digestion | 0.88284085 |
| 117 | MP0005620_abnormal_muscle_contractility | 0.88023475 |
| 118 | MP0001533_abnormal_skeleton_physiology | 0.86912785 |
| 119 | MP0000569_abnormal_digit_pigmentation | 0.85843496 |
| 120 | MP0008874_decreased_physiological_sensi | 0.85760313 |
| 121 | MP0004043_abnormal_pH_regulation | 0.84609591 |
| 122 | MP0002089_abnormal_postnatal_growth/wei | 0.83310617 |
| 123 | MP0003075_altered_response_to | 0.83021137 |
| 124 | MP0002069_abnormal_eating/drinking_beha | 0.82714213 |
| 125 | MP0005645_abnormal_hypothalamus_physiol | 0.82511424 |
| 126 | MP0002971_abnormal_brown_adipose | 0.81677961 |
| 127 | MP0005646_abnormal_pituitary_gland | 0.81199912 |
| 128 | MP0000685_abnormal_immune_system | 0.79743791 |
| 129 | MP0000534_abnormal_ureter_morphology | 0.79633569 |
| 130 | MP0002933_joint_inflammation | 0.79028893 |
| 131 | MP0003137_abnormal_impulse_conducting | 0.77254997 |
| 132 | MP0005464_abnormal_platelet_physiology | 0.77012544 |
| 133 | MP0002653_abnormal_ependyma_morphology | 0.75816677 |
| 134 | MP0005187_abnormal_penis_morphology | 0.74721718 |
| 135 | MP0005167_abnormal_blood-brain_barrier | 0.74668746 |
| 136 | MP0001502_abnormal_circadian_rhythm | 0.73980608 |
| 137 | MP0009384_cardiac_valve_regurgitation | 0.73896343 |
| 138 | MP0009333_abnormal_splenocyte_physiolog | 0.73266004 |
| 139 | MP0003634_abnormal_glial_cell | 0.73129139 |
| 140 | MP0002419_abnormal_innate_immunity | 0.73034923 |
| 141 | MP0002998_abnormal_bone_remodeling | 0.70874203 |
| 142 | MP0002972_abnormal_cardiac_muscle | 0.70698963 |
| 143 | MP0003045_fibrosis | 0.70472163 |
| 144 | MP0008872_abnormal_physiological_respon | 0.70230918 |
| 145 | MP0008775_abnormal_heart_ventricle | 0.69545680 |
| 146 | MP0002106_abnormal_muscle_physiology | 0.69336227 |
| 147 | MP0000733_abnormal_muscle_development | 0.68926593 |
| 148 | MP0002229_neurodegeneration | 0.68446559 |
| 149 | MP0004142_abnormal_muscle_tone | 0.67581795 |
| 150 | MP0001177_atelectasis | 0.67128738 |
| 151 | MP0003123_paternal_imprinting | 0.66782634 |
| 152 | MP0005369_muscle_phenotype | 0.66374656 |
| 153 | MP0005535_abnormal_body_temperature | 0.65536964 |
| 154 | MP0003566_abnormal_cell_adhesion | 0.65514735 |
| 155 | MP0002896_abnormal_bone_mineralization | 0.64907755 |
| 156 | MP0005023_abnormal_wound_healing | 0.64898935 |
| 157 | MP0001915_intracranial_hemorrhage | 0.64774186 |
| 158 | MP0001800_abnormal_humoral_immune | 0.64539225 |
| 159 | MP0002420_abnormal_adaptive_immunity | 0.62834917 |
| 160 | MP0001819_abnormal_immune_cell | 0.61028826 |
| 161 | MP0003115_abnormal_respiratory_system | 0.60126288 |
| 162 | MP0005390_skeleton_phenotype | 0.59784234 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 5.33037181 |
| 2 | Focal motor seizures (HP:0011153) | 5.00989627 |
| 3 | Visual hallucinations (HP:0002367) | 4.28787989 |
| 4 | Focal seizures (HP:0007359) | 4.25861639 |
| 5 | Action tremor (HP:0002345) | 3.50767085 |
| 6 | Abnormality of the lower motor neuron (HP:0002366) | 3.32778172 |
| 7 | Obstructive sleep apnea (HP:0002870) | 3.27534370 |
| 8 | Atonic seizures (HP:0010819) | 3.25515584 |
| 9 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.22360992 |
| 10 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.07230248 |
| 11 | Epileptic encephalopathy (HP:0200134) | 3.04982148 |
| 12 | Neurofibrillary tangles (HP:0002185) | 3.02113428 |
| 13 | Ankle clonus (HP:0011448) | 3.01441820 |
| 14 | Absence seizures (HP:0002121) | 2.95006277 |
| 15 | Generalized tonic-clonic seizures (HP:0002069) | 2.85441816 |
| 16 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.85390163 |
| 17 | Depression (HP:0000716) | 2.83172766 |
| 18 | Dysmetric saccades (HP:0000641) | 2.80889816 |
| 19 | Progressive cerebellar ataxia (HP:0002073) | 2.73675190 |
| 20 | Ventricular fibrillation (HP:0001663) | 2.72743376 |
| 21 | Pheochromocytoma (HP:0002666) | 2.72275333 |
| 22 | Poor eye contact (HP:0000817) | 2.64934747 |
| 23 | Abnormal social behavior (HP:0012433) | 2.64707479 |
| 24 | Impaired social interactions (HP:0000735) | 2.64707479 |
| 25 | Cerebral inclusion bodies (HP:0100314) | 2.64611267 |
| 26 | Supranuclear gaze palsy (HP:0000605) | 2.63745005 |
| 27 | Myopathic facies (HP:0002058) | 2.61875224 |
| 28 | Dialeptic seizures (HP:0011146) | 2.61214550 |
| 29 | Febrile seizures (HP:0002373) | 2.59689129 |
| 30 | Foot dorsiflexor weakness (HP:0009027) | 2.54082849 |
| 31 | Bundle branch block (HP:0011710) | 2.53530317 |
| 32 | Vertebral compression fractures (HP:0002953) | 2.53317243 |
| 33 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.51803870 |
| 34 | Rhabdomyolysis (HP:0003201) | 2.50627313 |
| 35 | Insidious onset (HP:0003587) | 2.44990388 |
| 36 | Termporal pattern (HP:0011008) | 2.44990388 |
| 37 | Upper limb amyotrophy (HP:0009129) | 2.44634965 |
| 38 | Distal upper limb amyotrophy (HP:0007149) | 2.44634965 |
| 39 | Urinary urgency (HP:0000012) | 2.43791822 |
| 40 | Torticollis (HP:0000473) | 2.42546847 |
| 41 | Growth hormone excess (HP:0000845) | 2.42512329 |
| 42 | Myotonia (HP:0002486) | 2.42012814 |
| 43 | Exercise-induced myalgia (HP:0003738) | 2.40722866 |
| 44 | Distal lower limb muscle weakness (HP:0009053) | 2.39492424 |
| 45 | Postural instability (HP:0002172) | 2.37124756 |
| 46 | Neuroendocrine neoplasm (HP:0100634) | 2.34234292 |
| 47 | Neuronal loss in central nervous system (HP:0002529) | 2.33435466 |
| 48 | Distal lower limb amyotrophy (HP:0008944) | 2.33391426 |
| 49 | Stridor (HP:0010307) | 2.32790407 |
| 50 | Hypercortisolism (HP:0001578) | 2.29051005 |
| 51 | Dysdiadochokinesis (HP:0002075) | 2.27611419 |
| 52 | Abnormality of the foot musculature (HP:0001436) | 2.26748251 |
| 53 | Annular pancreas (HP:0001734) | 2.26411046 |
| 54 | Resting tremor (HP:0002322) | 2.26203792 |
| 55 | Increased connective tissue (HP:0009025) | 2.26166773 |
| 56 | Sudden death (HP:0001699) | 2.25769960 |
| 57 | Hyperparathyroidism (HP:0000843) | 2.23677981 |
| 58 | Abnormality of pain sensation (HP:0010832) | 2.23532870 |
| 59 | Impaired pain sensation (HP:0007328) | 2.23532870 |
| 60 | Anxiety (HP:0000739) | 2.23418846 |
| 61 | Truncal ataxia (HP:0002078) | 2.22582248 |
| 62 | Achilles tendon contracture (HP:0001771) | 2.21689644 |
| 63 | Pointed chin (HP:0000307) | 2.21198361 |
| 64 | Hand muscle atrophy (HP:0009130) | 2.20317558 |
| 65 | Focal dystonia (HP:0004373) | 2.19856559 |
| 66 | Dysostosis multiplex (HP:0000943) | 2.19207614 |
| 67 | Insomnia (HP:0100785) | 2.18265682 |
| 68 | Eczematoid dermatitis (HP:0000976) | 2.17518162 |
| 69 | Hemiplegia (HP:0002301) | 2.16031680 |
| 70 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.15292228 |
| 71 | Genetic anticipation (HP:0003743) | 2.14608547 |
| 72 | Deep venous thrombosis (HP:0002625) | 2.13316653 |
| 73 | Abnormal eating behavior (HP:0100738) | 2.12229267 |
| 74 | Neoplasm of the heart (HP:0100544) | 2.10891340 |
| 75 | Rapidly progressive (HP:0003678) | 2.10482152 |
| 76 | Hypoventilation (HP:0002791) | 2.07897782 |
| 77 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.07518958 |
| 78 | Flat acetabular roof (HP:0003180) | 2.07094760 |
| 79 | Abnormality of the Achilles tendon (HP:0005109) | 2.06959657 |
| 80 | Exercise-induced muscle cramps (HP:0003710) | 2.06156509 |
| 81 | Craniofacial dystonia (HP:0012179) | 2.05106414 |
| 82 | Cerebral aneurysm (HP:0004944) | 2.05049823 |
| 83 | Nuclear cataract (HP:0100018) | 2.04936375 |
| 84 | Impaired smooth pursuit (HP:0007772) | 2.04611007 |
| 85 | Amblyopia (HP:0000646) | 2.04310362 |
| 86 | Mitral regurgitation (HP:0001653) | 2.03008528 |
| 87 | Broad face (HP:0000283) | 2.02668662 |
| 88 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.01975592 |
| 89 | Asymmetric septal hypertrophy (HP:0001670) | 2.00586488 |
| 90 | Increased variability in muscle fiber diameter (HP:0003557) | 1.98708018 |
| 91 | Atelectasis (HP:0100750) | 1.98006346 |
| 92 | Cellulitis (HP:0100658) | 1.97842737 |
| 93 | Purpura (HP:0000979) | 1.97659130 |
| 94 | Gaze-evoked nystagmus (HP:0000640) | 1.96926820 |
| 95 | Dysmetria (HP:0001310) | 1.96845580 |
| 96 | Difficulty climbing stairs (HP:0003551) | 1.95489968 |
| 97 | Colitis (HP:0002583) | 1.94017716 |
| 98 | Status epilepticus (HP:0002133) | 1.93214452 |
| 99 | Thin bony cortex (HP:0002753) | 1.92912288 |
| 100 | Muscle stiffness (HP:0003552) | 1.92851933 |
| 101 | Protrusio acetabuli (HP:0003179) | 1.92691495 |
| 102 | Bradykinesia (HP:0002067) | 1.92659533 |
| 103 | Progressive muscle weakness (HP:0003323) | 1.88982465 |
| 104 | Hyporeflexia of lower limbs (HP:0002600) | 1.88766745 |
| 105 | Hammertoe (HP:0001765) | 1.87582257 |
| 106 | Axonal loss (HP:0003447) | 1.86353579 |
| 107 | Diplopia (HP:0000651) | 1.86128582 |
| 108 | Abnormality of binocular vision (HP:0011514) | 1.86128582 |
| 109 | Turricephaly (HP:0000262) | 1.85850237 |
| 110 | Shoulder girdle muscle weakness (HP:0003547) | 1.85530747 |
| 111 | Postural tremor (HP:0002174) | 1.84976964 |
| 112 | Lower limb muscle weakness (HP:0007340) | 1.84761148 |
| 113 | Lower limb amyotrophy (HP:0007210) | 1.84711746 |
| 114 | Difficulty running (HP:0009046) | 1.84079009 |
| 115 | Ragged-red muscle fibers (HP:0003200) | 1.83682452 |
| 116 | Peripheral hypomyelination (HP:0007182) | 1.82919356 |
| 117 | Spastic gait (HP:0002064) | 1.82776605 |
| 118 | Spinal canal stenosis (HP:0003416) | 1.82531911 |
| 119 | Impaired vibratory sensation (HP:0002495) | 1.81784849 |
| 120 | Striae distensae (HP:0001065) | 1.80882741 |
| 121 | Epileptiform EEG discharges (HP:0011182) | 1.80835843 |
| 122 | Hyperthyroidism (HP:0000836) | 1.80606150 |
| 123 | Type 1 muscle fiber predominance (HP:0003803) | 1.80512111 |
| 124 | Round ear (HP:0100830) | 1.80441947 |
| 125 | Bulbar palsy (HP:0001283) | 1.80285832 |
| 126 | Broad-based gait (HP:0002136) | 1.79874470 |
| 127 | Hyperacusis (HP:0010780) | 1.79522657 |
| 128 | Prolonged QT interval (HP:0001657) | 1.79252889 |
| 129 | Interstitial pulmonary disease (HP:0006530) | 1.76457127 |
| 130 | Gout (HP:0001997) | 1.75767048 |
| 131 | Hemorrhage of the eye (HP:0011885) | 1.75409117 |
| 132 | Megalencephaly (HP:0001355) | 1.75338819 |
| 133 | EEG with generalized epileptiform discharges (HP:0011198) | 1.75161579 |
| 134 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.74385311 |
| 135 | Mucopolysacchariduria (HP:0008155) | 1.74385311 |
| 136 | Agitation (HP:0000713) | 1.73832630 |
| 137 | Hypsarrhythmia (HP:0002521) | 1.73250440 |
| 138 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.73225953 |
| 139 | Abnormal EKG (HP:0003115) | 1.73218185 |
| 140 | Papilledema (HP:0001085) | 1.72638066 |
| 141 | Failure to thrive in infancy (HP:0001531) | 1.72151167 |
| 142 | Myoglobinuria (HP:0002913) | 1.71814428 |
| 143 | Shallow orbits (HP:0000586) | 1.71077299 |
| 144 | Menstrual irregularities (HP:0000858) | 1.70798728 |
| 145 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.69497346 |
| 146 | Muscle fiber inclusion bodies (HP:0100299) | 1.68963616 |
| 147 | Long palpebral fissure (HP:0000637) | 1.68614575 |
| 148 | Increased IgE level (HP:0003212) | 1.68222991 |
| 149 | Muscle fiber splitting (HP:0003555) | 1.67759056 |
| 150 | Limb-girdle muscle atrophy (HP:0003797) | 1.65771391 |
| 151 | Pelvic girdle muscle weakness (HP:0003749) | 1.64857194 |
| 152 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.64670956 |
| 153 | Systemic lupus erythematosus (HP:0002725) | 1.64050119 |
| 154 | Spinal rigidity (HP:0003306) | 1.62607092 |
| 155 | Polygenic inheritance (HP:0010982) | 1.62100854 |
| 156 | Hyperphosphatemia (HP:0002905) | 1.61971654 |
| 157 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.60833338 |
| 158 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.60833338 |
| 159 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.60833338 |
| 160 | Ulnar deviation of the wrist (HP:0003049) | 1.60799896 |
| 161 | Diminished motivation (HP:0000745) | 1.60483361 |
| 162 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.60482984 |
| 163 | Generalized amyotrophy (HP:0003700) | 1.60480758 |
| 164 | J-shaped sella turcica (HP:0002680) | 1.59648259 |
| 165 | Lower limb asymmetry (HP:0100559) | 1.59177338 |
| 166 | Decreased motor nerve conduction velocity (HP:0003431) | 1.58854480 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.60351689 |
| 2 | MAP3K9 | 3.55656373 |
| 3 | MAP3K11 | 3.10677807 |
| 4 | EPHA4 | 2.96556501 |
| 5 | TAOK2 | 2.80706059 |
| 6 | DAPK2 | 2.77553478 |
| 7 | MAP3K4 | 2.58152696 |
| 8 | PRKD3 | 2.58112250 |
| 9 | MAP2K3 | 2.57568729 |
| 10 | TRIB3 | 2.56991773 |
| 11 | KSR2 | 2.53175719 |
| 12 | MINK1 | 2.53007805 |
| 13 | PAK6 | 2.52399895 |
| 14 | NTRK1 | 2.20665904 |
| 15 | NEK1 | 2.15539485 |
| 16 | CAMKK1 | 2.04691832 |
| 17 | ERN1 | 2.00697698 |
| 18 | MAP3K3 | 1.99436625 |
| 19 | ICK | 1.97867979 |
| 20 | MAP2K4 | 1.87556707 |
| 21 | PKN2 | 1.86847093 |
| 22 | PHKG2 | 1.77950869 |
| 23 | PHKG1 | 1.77950869 |
| 24 | RIPK1 | 1.70877970 |
| 25 | MKNK2 | 1.68632110 |
| 26 | MAP2K7 | 1.62965574 |
| 27 | LATS2 | 1.62795622 |
| 28 | FGFR4 | 1.61738359 |
| 29 | MAP3K2 | 1.56380479 |
| 30 | DAPK1 | 1.55562222 |
| 31 | KSR1 | 1.53481880 |
| 32 | STK38 | 1.51014254 |
| 33 | LMTK2 | 1.50805527 |
| 34 | SMG1 | 1.46592152 |
| 35 | MARK1 | 1.36122992 |
| 36 | IRAK3 | 1.33078717 |
| 37 | RET | 1.31831584 |
| 38 | CDK5 | 1.28759406 |
| 39 | JAK3 | 1.21394175 |
| 40 | CDK19 | 1.19043525 |
| 41 | FER | 1.16934472 |
| 42 | MAP4K1 | 1.16428111 |
| 43 | ARAF | 1.16363161 |
| 44 | PLK2 | 1.14950338 |
| 45 | EPHB1 | 1.14377058 |
| 46 | CAMKK2 | 1.14365294 |
| 47 | PAK3 | 1.11552831 |
| 48 | TAOK1 | 1.10587744 |
| 49 | TTN | 1.09505523 |
| 50 | NTRK2 | 1.07522408 |
| 51 | PDGFRA | 1.07167618 |
| 52 | MAP3K12 | 1.07095069 |
| 53 | SCYL2 | 1.06913807 |
| 54 | PRPF4B | 1.02783578 |
| 55 | UHMK1 | 1.02387720 |
| 56 | GRK5 | 1.01894780 |
| 57 | ALK | 1.01517060 |
| 58 | DDR2 | 1.00207262 |
| 59 | PRKCH | 0.99828231 |
| 60 | MAPK12 | 0.96025376 |
| 61 | PRKCG | 0.95320333 |
| 62 | TYRO3 | 0.94375249 |
| 63 | CDK14 | 0.89446205 |
| 64 | PTK2B | 0.88971560 |
| 65 | CDK18 | 0.86727915 |
| 66 | MAP2K1 | 0.86590321 |
| 67 | DYRK1B | 0.86579007 |
| 68 | CDK15 | 0.85747807 |
| 69 | ZAP70 | 0.85700767 |
| 70 | DAPK3 | 0.84298950 |
| 71 | SGK223 | 0.82878097 |
| 72 | SGK494 | 0.82878097 |
| 73 | PRKD2 | 0.82226799 |
| 74 | TBK1 | 0.82121677 |
| 75 | MAP3K1 | 0.80762149 |
| 76 | MAP3K7 | 0.80642151 |
| 77 | LRRK2 | 0.77802062 |
| 78 | MAP3K6 | 0.77641115 |
| 79 | CDC42BPA | 0.76913772 |
| 80 | CAMK1 | 0.75955281 |
| 81 | SGK3 | 0.75821620 |
| 82 | TYK2 | 0.75429825 |
| 83 | SIK2 | 0.74209435 |
| 84 | CDK11A | 0.73150114 |
| 85 | PDK4 | 0.72577684 |
| 86 | PDK3 | 0.72577684 |
| 87 | LIMK1 | 0.72279842 |
| 88 | BRAF | 0.71881074 |
| 89 | PTK2 | 0.71808363 |
| 90 | ABL2 | 0.71415263 |
| 91 | MOS | 0.70996284 |
| 92 | FES | 0.70928950 |
| 93 | TNK2 | 0.69851458 |
| 94 | STK11 | 0.68632233 |
| 95 | DMPK | 0.67932653 |
| 96 | DYRK1A | 0.67873805 |
| 97 | PDPK1 | 0.65103703 |
| 98 | EPHA2 | 0.65099559 |
| 99 | TESK2 | 0.64302677 |
| 100 | FGFR3 | 0.63935522 |
| 101 | PINK1 | 0.63039469 |
| 102 | PDK1 | 0.61953880 |
| 103 | MAP3K13 | 0.61469464 |
| 104 | CAMK2A | 0.61138166 |
| 105 | BMX | 0.61082565 |
| 106 | EEF2K | 0.60041597 |
| 107 | MAP2K2 | 0.58858937 |
| 108 | MAPK11 | 0.58644496 |
| 109 | HIPK2 | 0.57930493 |
| 110 | RIPK4 | 0.56976451 |
| 111 | RAF1 | 0.54855141 |
| 112 | SGK2 | 0.54705350 |
| 113 | CAMK4 | 0.53488764 |
| 114 | RPS6KA2 | 0.51432396 |
| 115 | PIM2 | 0.50078615 |
| 116 | RPS6KL1 | 0.49927874 |
| 117 | RPS6KC1 | 0.49927874 |
| 118 | CDK12 | 0.49117166 |
| 119 | ROCK1 | 0.48927950 |
| 120 | EPHA3 | 0.48435812 |
| 121 | MAPK7 | 0.47508429 |
| 122 | CAMK2B | 0.46012648 |
| 123 | FGFR1 | 0.45515498 |
| 124 | MTOR | 0.45499342 |
| 125 | CAMK2G | 0.44973925 |
| 126 | MAP2K6 | 0.44609919 |
| 127 | WNK1 | 0.44483388 |
| 128 | IRAK2 | 0.43489389 |
| 129 | RPS6KA3 | 0.43378813 |
| 130 | MAP3K8 | 0.42772450 |
| 131 | CAMK1G | 0.41396040 |
| 132 | TESK1 | 0.41097243 |
| 133 | PTK6 | 0.41095652 |
| 134 | CAMK2D | 0.40711734 |
| 135 | MAPK4 | 0.40069969 |
| 136 | SGK1 | 0.39633545 |
| 137 | JAK1 | 0.39518393 |
| 138 | PRKCZ | 0.39245103 |
| 139 | NME1 | 0.38776024 |
| 140 | MAP3K5 | 0.38687852 |
| 141 | MARK2 | 0.38602004 |
| 142 | MAPKAPK3 | 0.37947525 |
| 143 | MAPK10 | 0.35695923 |
| 144 | SIK1 | 0.35298468 |
| 145 | ROCK2 | 0.34887401 |
| 146 | CSNK1G2 | 0.34787901 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.35922450 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 2.56795310 |
| 3 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.47170266 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.27759326 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 2.14098884 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.13905812 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.11469779 |
| 8 | Insulin secretion_Homo sapiens_hsa04911 | 2.05135370 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.02142650 |
| 10 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.95617856 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.94362336 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.91666393 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.86592925 |
| 14 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.86517954 |
| 15 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.78154278 |
| 16 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.77712033 |
| 17 | Morphine addiction_Homo sapiens_hsa05032 | 1.72507371 |
| 18 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.72203557 |
| 19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.68312111 |
| 20 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.67907898 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.67376627 |
| 22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.66372251 |
| 23 | Salivary secretion_Homo sapiens_hsa04970 | 1.63382654 |
| 24 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.62535586 |
| 25 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.59737546 |
| 26 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.48656764 |
| 27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.42945197 |
| 28 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.42848609 |
| 29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.36737551 |
| 30 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.36267417 |
| 31 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.35990323 |
| 32 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.35752628 |
| 33 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.35550812 |
| 34 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.34884662 |
| 35 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.30469973 |
| 36 | Glioma_Homo sapiens_hsa05214 | 1.29922530 |
| 37 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.26980633 |
| 38 | Gap junction_Homo sapiens_hsa04540 | 1.25816329 |
| 39 | Cocaine addiction_Homo sapiens_hsa05030 | 1.23837892 |
| 40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.21608229 |
| 41 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.21114245 |
| 42 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.20708848 |
| 43 | Taste transduction_Homo sapiens_hsa04742 | 1.19449973 |
| 44 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.17797462 |
| 45 | Renin secretion_Homo sapiens_hsa04924 | 1.17213690 |
| 46 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.14863051 |
| 47 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.14774103 |
| 48 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.14714985 |
| 49 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.13780605 |
| 50 | Long-term depression_Homo sapiens_hsa04730 | 1.13745407 |
| 51 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.07672082 |
| 52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.05550780 |
| 53 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.00947453 |
| 54 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.99699883 |
| 55 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.98802958 |
| 56 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.98350486 |
| 57 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.96621872 |
| 58 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.95216492 |
| 59 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.94696787 |
| 60 | Melanogenesis_Homo sapiens_hsa04916 | 0.94179488 |
| 61 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.93814432 |
| 62 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.93225468 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.92192751 |
| 64 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.91817443 |
| 65 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91621240 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.91395832 |
| 67 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.90925978 |
| 68 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.90517586 |
| 69 | Amoebiasis_Homo sapiens_hsa05146 | 0.90421917 |
| 70 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.89818617 |
| 71 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.89308485 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.87382065 |
| 73 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.85298829 |
| 74 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85172296 |
| 75 | Bile secretion_Homo sapiens_hsa04976 | 0.84918493 |
| 76 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.83562905 |
| 77 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.82284940 |
| 78 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.81641334 |
| 79 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.81511401 |
| 80 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.81307797 |
| 81 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81002778 |
| 82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.80091247 |
| 83 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79602166 |
| 84 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.78097853 |
| 85 | Hepatitis C_Homo sapiens_hsa05160 | 0.78018454 |
| 86 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77811086 |
| 87 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.76678806 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76546254 |
| 89 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.75426705 |
| 90 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.74785762 |
| 91 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.74262409 |
| 92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.72369994 |
| 93 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71672958 |
| 94 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.71657233 |
| 95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.68949244 |
| 96 | Salmonella infection_Homo sapiens_hsa05132 | 0.68412501 |
| 97 | Axon guidance_Homo sapiens_hsa04360 | 0.68298164 |
| 98 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.67941244 |
| 99 | Endometrial cancer_Homo sapiens_hsa05213 | 0.67411722 |
| 100 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.65133109 |
| 101 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64718522 |
| 102 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.64674769 |
| 103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61658741 |
| 104 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.61137476 |
| 105 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59858001 |
| 106 | Endocytosis_Homo sapiens_hsa04144 | 0.58845848 |
| 107 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.58730291 |
| 108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.57942138 |
| 109 | Tuberculosis_Homo sapiens_hsa05152 | 0.57688511 |
| 110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57156625 |
| 111 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57088026 |
| 112 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56202483 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.51801478 |
| 114 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.51364034 |
| 115 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.50670463 |
| 116 | Carbon metabolism_Homo sapiens_hsa01200 | 0.49090209 |
| 117 | Tight junction_Homo sapiens_hsa04530 | 0.47836679 |
| 118 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47735429 |
| 119 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.47353616 |
| 120 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.47033870 |
| 121 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.46781265 |
| 122 | Prion diseases_Homo sapiens_hsa05020 | 0.44734316 |
| 123 | Focal adhesion_Homo sapiens_hsa04510 | 0.44538503 |
| 124 | Bladder cancer_Homo sapiens_hsa05219 | 0.43580210 |
| 125 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42502209 |
| 126 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42133377 |
| 127 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.41742774 |
| 128 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.40609432 |
| 129 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.38986123 |
| 130 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37070630 |
| 131 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36589553 |
| 132 | Circadian rhythm_Homo sapiens_hsa04710 | 0.36101428 |

